Literature DB >> 26244610

Natural killer cell and gamma delta T cell alterations in enthesitis related arthritis category of juvenile idiopathic arthritis.

Priyanka Gaur1, Ramnath Misra1, Amita Aggarwal2.   

Abstract

Enthesitis related arthritis (ERA) is associated with increased frequency of Th17 cells and synovial fluid (SF) IL-17 levels. Natural killer (NK) and gamma delta T cells have been recently shown to produce IL-17, thus we studied the NK and gamma delta-T cells in peripheral blood (PB) of 50 ERA, 16 other JIA patients and 19 healthy controls. We have analyzed the frequency of NK (total, CD56dim, CD56bright) and gamma delta-T cells, perforin and KIR3DL1/2 expression on NK cells and IL-17 and IFN-gamma production by them using flow cytometry. ERA patients had more NK cells with reduced perforin expression and IFN-gamma production but increased KIR3DL1/2 expression and IL-17 production as compared to controls. Also IL-17 producing gamma delta-T were increased in PB of ERA patients. Paired SF samples had NK cells with reduced perforin and KIR3DL expression. Thus increased NK and gamma delta-T cells may contribute to the inflammation in ERA by producing IL-17.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Childhood arthritis; Inflammation; Innate immune cells; Killer immunoglobulin-like receptors; Perforin; Synovial fluid

Mesh:

Substances:

Year:  2015        PMID: 26244610     DOI: 10.1016/j.clim.2015.07.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

Review 1.  The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.

Authors:  Judith A Smith
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

2.  Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis.

Authors:  P Gaur; A Myles; R Misra; A Aggarwal
Journal:  Clin Exp Immunol       Date:  2016-10-28       Impact factor: 4.330

3.  Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.

Authors:  S Chaurasia; A K Shasany; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

Review 4.  HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.

Authors:  Robert Busch; Simon Kollnberger; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

Review 5.  Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis.

Authors:  Fabiola Atzeni; Antonio Carriero; Laura Boccassini; Salvatore D'Angelo
Journal:  Immunotargets Ther       Date:  2021-05-03

Review 6.  Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis.

Authors:  Akihiro Nakamura; Shaghayegh Foroozan Boroojeni; Nigil Haroon
Journal:  Semin Immunopathol       Date:  2021-02-02       Impact factor: 11.759

Review 7.  Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.

Authors:  Annika Reinhardt; Immo Prinz
Journal:  Front Immunol       Date:  2018-04-25       Impact factor: 7.561

Review 8.  Innate Lymphocytes in Inflammatory Arthritis.

Authors:  Xunyao Wu
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 9.  Cytokine "fine tuning" of enthesis tissue homeostasis as a pointer to spondyloarthritis pathogenesis with a focus on relevant TNF and IL-17 targeted therapies.

Authors:  Tobias Russell; Charlie Bridgewood; Hannah Rowe; Ala Altaie; Elena Jones; Dennis McGonagle
Journal:  Semin Immunopathol       Date:  2021-02-05       Impact factor: 11.759

Review 10.  The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases.

Authors:  Ilan Bank
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.